Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
Status:
Completed
Trial end date:
2018-08-22
Target enrollment:
Participant gender:
Summary
This trial is conducted globally. The aim of the trial is to investigate the efficacy and
safety of oral semaglutide versus placebo in subjects with Type 2 Diabetes Mellitus treated
with insulin. All subjects should continue their pre-trial insulin therapy (basal,
basal-bolus or premixed regimen including combinations of soluble insulins) throughout the
trial. Subjects treated with metformin in addition to insulin treatment must continue their
metformin treatment throughout the entire trial.